| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies
|
Santella, Christina
|
|
|
38 |
11 |
p. 816-825
|
artikel
|
| 2 |
Association of Bacillus Calmette–Guerin shortages with bladder cancer recurrence: A single-center retrospective study
|
Lee, Sangmin
|
|
|
38 |
11 |
p. 851.e11-851.e17
|
artikel
|
| 3 |
Changes in health-related quality of life outcomes in older patients with kidney cancer: A longitudinal cohort analysis with matched controls
|
Bhandari, Naleen Raj
|
|
|
38 |
11 |
p. 852.e11-852.e20
|
artikel
|
| 4 |
Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer
|
Stevens, Erica
|
|
|
38 |
11 |
p. 846.e9-846.e16
|
artikel
|
| 5 |
Combination of NDRG2 overexpression, X-ray radiation and docetaxel enhances apoptosis and inhibits invasiveness properties of LNCaP cells
|
Alizadeh Zarei, Marziyeh
|
|
|
38 |
11 |
p. 849.e1-849.e9
|
artikel
|
| 6 |
Commentary: Contemporary trends in percutaneous renal mass biopsy in the United States by Ozambela et al.
|
Loughlin, Kevin R.
|
|
|
38 |
11 |
p. 844-845
|
artikel
|
| 7 |
Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis
|
Kumar, Jatinder
|
|
|
38 |
11 |
p. 826-834
|
artikel
|
| 8 |
Concordance of confirmatory prostate biopsy in active surveillance with national guidelines: An analysis from the multi-institutional PURC cohort
|
Talwar, Ruchika
|
|
|
38 |
11 |
p. 846.e17-846.e22
|
artikel
|
| 9 |
Contemporary trends in percutaneous renal mass biopsy utilization in the United States
|
Ozambela Jr.,, Manuel
|
|
|
38 |
11 |
p. 835-843
|
artikel
|
| 10 |
Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer
|
Kafka, Mona
|
|
|
38 |
11 |
p. 801-815
|
artikel
|
| 11 |
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study
|
Diamand, Romain
|
|
|
38 |
11 |
p. 847.e9-847.e16
|
artikel
|
| 12 |
Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer – examining the utility of classifying Ta bladder cancer based on size
|
Tully, Karl H.
|
|
|
38 |
11 |
p. 851.e19-851.e25
|
artikel
|
| 13 |
Long-term outcomes of incidental prostate cancer at radical cystectomy
|
Packiam, Vignesh T.
|
|
|
38 |
11 |
p. 848.e17-848.e22
|
artikel
|
| 14 |
Long term outcomes of ureteroscopic management of upper tract urothelial carcinoma
|
Scotland, Kymora B.
|
|
|
38 |
11 |
p. 850.e17-850.e26
|
artikel
|
| 15 |
Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes
|
Piraino, Javier A.
|
|
|
38 |
11 |
p. 851.e1-851.e10
|
artikel
|
| 16 |
Phase I trial of docetaxel plus lutetium-177-labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer
|
Batra, Jaspreet S.
|
|
|
38 |
11 |
p. 848.e9-848.e16
|
artikel
|
| 17 |
Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy
|
Shiota, Masaki
|
|
|
38 |
11 |
p. 849.e11-849.e18
|
artikel
|
| 18 |
Practice patterns for extended venous thromboembolism chemoprophylaxis among urologic oncologists after radical cystectomy
|
Dall, Christopher P.
|
|
|
38 |
11 |
p. 849.e19-849.e23
|
artikel
|
| 19 |
Preoperative nomogram predicting 12-year probability of metastatic renal cancer – evaluation in a contemporary cohort
|
Mano, Roy
|
|
|
38 |
11 |
p. 853.e1-853.e7
|
artikel
|
| 20 |
Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer
|
Su, Shiqiang
|
|
|
38 |
11 |
p. 852.e1-852.e9
|
artikel
|
| 21 |
Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk Calculator
|
Presti Jr.,, Joseph
|
|
|
38 |
11 |
p. 847.e1-847.e8
|
artikel
|
| 22 |
Reliability of urinalysis for identification of proteinuria is reduced in the presence of other abnormalities including high specific gravity and hematuria
|
Parker, Jessica L.
|
|
|
38 |
11 |
p. 853.e9-853.e15
|
artikel
|
| 23 |
Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure
|
Juvet, Tristan
|
|
|
38 |
11 |
p. 850.e9-850.e15
|
artikel
|
| 24 |
The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer
|
Bacchetta, Frédéric
|
|
|
38 |
11 |
p. 846.e1-846.e7
|
artikel
|
| 25 |
Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study
|
Lec, Patrick M.
|
|
|
38 |
11 |
p. 854.e1-854.e9
|
artikel
|
| 26 |
Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease?
|
Tachibana, Isamu
|
|
|
38 |
11 |
p. 850.e1-850.e7
|
artikel
|
| 27 |
Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice
|
Sanmamed, Noelia
|
|
|
38 |
11 |
p. 848.e1-848.e7
|
artikel
|
Tijdschrift beschrijving